Can checking blood pressure at home improve pregnancy outcomes?
NCT ID NCT07115199
First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times
Summary
This pilot study will test whether having pregnant women with chronic hypertension measure their blood pressure at home and adjust medications remotely can lead to better outcomes than standard in-office checks. Fifty participants will be randomly assigned to remote monitoring or usual care. The goal is to see if this approach is feasible and might reduce complications like preterm birth or preeclampsia.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Remote patient monitoring (blood pressure self-measurement at home)
- What this could lead to
- If successful, this approach could make blood pressure management during pregnancy more convenient and potentially reduce complications like preterm birth.
- What could go wrong
- This is a very small pilot study (50 participants) testing feasibility, not effectiveness. It may not show clear benefits, and home monitoring might miss some issues detected in clinic.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Nov 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 55 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18 or older * Patients with a viable pregnancy \<23 weeks of gestation * Chronic hypertension is defined as: 1) Currently receiving treatment for hypertensive disorders OR 2) Newly diagnosed or untreated chronic hypertension is defined as systolic blood pressure \>=140 mm Hg or diastolic blood pressure \>=90 mm Hg prior to 20 weeks of gestation * Viable pregnancy \<23 weeks of gestation * Ability to follow directions * Ability to consent * Speak English or Spanish Exclusion Criteria: * Known secondary cause of hypertension * Known major fetal anomaly * Known fetal demise * Suspected fetal growth restriction * Membrane rupture * Planned termination * Plan to deliver outside of the RWJ Barnabas Health system * Known sensitivity to labetalol or nifedipine * Unlikely to follow up, in the opinion of the study staff. * Any medical condition that the providers feel is a contraindication to the REACH algorithm. * Unwillingness to take blood pressure at home
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic hypertension in pregnancy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey, 08901, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.